These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1540494)

  • 1. Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck.
    Holding JD; Lindup WE; van Laer C; Vreeburg GC; Schilling V; Wilson JA; Stell PM
    Br J Clin Pharmacol; 1992 Jan; 33(1):75-81. PubMed ID: 1540494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
    Holding JD; Lindup WE; Bowdler DA; Siodlak MZ; Stell PM
    Br J Clin Pharmacol; 1991 Aug; 32(2):173-9. PubMed ID: 1931468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN).
    Camille N; Rozehnal J; Roy E; Uczkowski D; Olson A; Genden E; Teng M; Bakst R; Gupta V; Posner M; Misiukiewicz K
    Oral Oncol; 2017 Aug; 71():99-104. PubMed ID: 28688700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In squamous cell head and neck cancer: which platinum, how much and how often?
    Nwizu T; Adelstein DJ
    Expert Rev Anticancer Ther; 2014 Sep; 14(9):1033-9. PubMed ID: 24998393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
    Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
    BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between hematotoxicity and serum albumin level in the treatment of head and neck cancers with concurrent chemoradiotherapy using cisplatin.
    Ishizuka M; Fujimoto Y; Itoh Y; Kitagawa K; Sano M; Miyagawa Y; Ando A; Hiramatsu M; Hirasawa N; Ishihara S; Nakashima T; Yamada K
    Jpn J Clin Oncol; 2011 Aug; 41(8):973-9. PubMed ID: 21693483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor concentration of platinum in patients with head and neck cancer.
    Mattox DE; Sternson LA; Von Hoff DD; Kuhn JG; Repta AJ
    Otolaryngol Head Neck Surg; 1983 Jun; 91(3):271-5. PubMed ID: 6410327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
    J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.
    Rischin D; Peters L; Hicks R; Hughes P; Fisher R; Hart R; Sexton M; D'Costa I; von Roemeling R
    J Clin Oncol; 2001 Jan; 19(2):535-42. PubMed ID: 11208848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I-II trial of cisplatin and dichloromethotrexate in squamous cell cancer of the head and neck.
    Wheeler RH; Natale RB; Roshon SG; Baker SR
    J Clin Oncol; 1984 Jul; 2(7):831-5. PubMed ID: 6539813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.
    Dasmahapatra KS; Citrin P; Hill GJ; Yee R; Mohit-Tabatabai MA; Rush BF
    J Clin Oncol; 1985 Nov; 3(11):1486-9. PubMed ID: 4056841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck.
    Posner MR; Glisson B; Frenette G; Al-Sarraf M; Colevas AD; Norris CM; Seroskie JD; Shin DM; Olivares R; Garay CA
    J Clin Oncol; 2001 Feb; 19(4):1096-104. PubMed ID: 11181674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A cooperative phase II study of cisplatin in patients with head and neck cancer].
    Inuyama Y; Takeda C
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):232-8. PubMed ID: 3004363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study.
    Chen SC; Chang PM; Yang MH
    Oncologist; 2016 May; 21(5):537-8. PubMed ID: 27091418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.
    Demirci NS; Aksoy S; Özdemir NY; Erdem GU; Ozcelik M; Tanrikulu E; Eren T; Bozkaya Y; Sahin S; Başol F; Aslan SA; Zengin N; Güllü İ
    Curr Med Res Opin; 2017 Mar; 33(3):401-407. PubMed ID: 27817239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study.
    Siu LL; Soulieres D; Chen EX; Pond GR; Chin SF; Francis P; Harvey L; Klein M; Zhang W; Dancey J; Eisenhauer EA; Winquist E; ;
    J Clin Oncol; 2007 Jun; 25(16):2178-83. PubMed ID: 17538162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
    Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.